Jump to content

Chronic obstructive pulmonary disease: Difference between revisions

Chronic obstructive pulmonary disease (view source)

Revision as of 13:41, 17 October 2023

5,495 bytes added ,  17 October 2023
Created page with "'''Chronic obstructive pulmonary disease''' (COPD) is characterised by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. It’s common, preventable, and treatable. It is defined as a post-bronchodilator FEV1/FVC ratio of < 0,70. It affects 11,7% of the world and it’s the third leading cause of death worldwide. Prevalence is expected to rise, and it’s expected to be the leading cause of death in 15 years. COPD ha..."
(Created page with "'''Chronic obstructive pulmonary disease''' (COPD) is characterised by persistent respiratory symptoms and airflow limitation due to airway and/or alveolar abnormalities. It’s common, preventable, and treatable. It is defined as a post-bronchodilator FEV1/FVC ratio of < 0,70. It affects 11,7% of the world and it’s the third leading cause of death worldwide. Prevalence is expected to rise, and it’s expected to be the leading cause of death in 15 years. COPD ha...")
(No difference)